Effectiveness of an 8-week Independent Cadence Retraining Program on Stress Urinary Incontinence in Parous Runners.

NCT07829692 | Recruiting

• 1 other identifier: 26-000371
• Study Type: interventional
• Target: 66
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this research is to assess the impact of an eight-week home cadence training program on stress urinary incontinence symptoms in parous women.

Conditions

Stress Urinary Incontinence

Outcome Measures

Primary Outcomes (5)

• Preferred Cadence

  Participants will self-assess preferred running cadence using a garmin device during a 15 minute self-paced run.

  Baseline and 8 weeks

• The Pelvic Floor Distress Inventory-20 (PFDI-20)

  questionnaire that assesses bowel, bladder, and pelvic symptoms and their impact on quality of life. Scores range from 0 to 300 with higher scores indicating greater pelvic floor distress and impact on quality of life.

  Baseline, 8 weeks, and 6 month

• Questionnaire for Female Urinary Incontinence Diagnosis (QUID)

  6 item urinary incontinence questionnaire. A higher SUI score (range 0-15) suggests stress urinary incontinence is more likely. A higher UUI score (range 0-15) suggests urge urinary incontinence is more likely. The questionnaire is designed to help distinguish between these two main types of urinary incontinence in women.

  Baseline, 8 weeks, and 6 months

• International Consultation on Incontinence Questionnaire - Urinary Incontinence (ICIQ-UI)

  The ICIQ-UI Short Form (ICIQ-UI SF) produces a single score from 0 to 21 by summing three scored items: leakage frequency, leakage amount, and impact on daily life. A higher score indicates increased severity of urinary incontinence symptoms.

  Baseline, 8 weeks, and 6 months

• Global Rating of Change (GROC)

  Scale allowing patient to self-report perceived change of UI symptoms. This is an 11-point scale (-5 to +5) with a higher positive score indicating greater improvement in SUI symptoms and a lower negative score indicating worsening of SUI symptoms.

  8 weeks and 6 months

Study Arms (2)

Cadence increase group

EXPERIMENTAL

Participants will log running data and set cadence alarms to increase running cadence by 10%

Other: Cadence Increase

Cadence Maintenance Arm

PLACEBO COMPARATOR

Participants will log their running data and set cadence alarm to maintain cadence.

Other: Cadence Maintenance

Interventions

Cadence Increase OTHER

Utilizing cadence alarm on a garmin device, the intervention group will attempt to increase their running cadence by 10%.

Cadence increase group

Cadence Maintenance OTHER

Participants will use cadence alarms to maintain preferred running cadence.

Cadence Maintenance Arm

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Healthy
• Nonpregnant
• Female volunteers
• Self-reported urinary incontinence during running with history of at least one prior delivery after 32 weeks gestation and who run 6 miles/week with a preferred cadence of less than or equal to 170 steps per minute determined via personal report from current Garmin watch data.
• Participants must own their own or have access to a Garmin watch.
• Participants must read, speak, and understand English sufficiently to provide informed consent and complete study procedures and questionnaires.

You may not qualify if:

• Unwillingness to complete all components of the study
• Urge only urinary incontinence
• \<3 months postpartum or current pregnancy
• History of prolapse repair or incontinence surgery
• Participants will also be excluded if they do not own or utilize a Garmin watch that provides cadence assessment and alarm.

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

RECRUITING

MeSH Terms

Conditions

Urinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Urinary Incontinence; Urination Disorders; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Lower Urinary Tract Symptoms; Urological Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Nicole Ron, PT, DPT

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Sally Olmstead

CONTACT

316-641-6192; olmstead.sally@mayo.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: September 15, 2026
• First Posted: September 21, 2026
• Study Start: August 5, 2026
• Primary Completion (Estimated): August 5, 2029
• Study Completion (Estimated): August 5, 2029
• Last Updated: September 23, 2026

Record last verified: 2026-09

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)